92 related articles for article (PubMed ID: 23548582)
41. Estrogen provokes the depressant effect of chronic nicotine on vagally mediated reflex chronotropism in female rats.
El-Mas MM; El-Gowelli HM; El-Gowilly SM; Fouda MA; Helmy MM
J Pharmacol Exp Ther; 2012 Aug; 342(2):568-75. PubMed ID: 22619254
[TBL] [Abstract][Full Text] [Related]
42. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
Malmström RE; Lundberg JN; Weitzberg E
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
[TBL] [Abstract][Full Text] [Related]
43. Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: Correlation with Y2 receptor plasticity.
Tu B; Jiao Y; Herzog H; Nadler JV
Neuroscience; 2006 Dec; 143(4):1085-94. PubMed ID: 17027162
[TBL] [Abstract][Full Text] [Related]
44. Role of adenosine A2A receptor signaling in the nicotine-evoked attenuation of reflex cardiac sympathetic control.
El-Mas MM; El-Gowilly SM; Fouda MA; Saad EI
Toxicol Appl Pharmacol; 2011 Aug; 254(3):229-37. PubMed ID: 21550361
[TBL] [Abstract][Full Text] [Related]
45. The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors.
Chu DQ; Cox HM; Costa SK; Herzog H; Brain SD
Br J Pharmacol; 2003 Sep; 140(2):422-30. PubMed ID: 12970079
[TBL] [Abstract][Full Text] [Related]
46. Neuropeptide Y modulates functions of inflammatory cells in the rat: distinct role for Y1, Y2 and Y5 receptors.
Mitić K; Stanojević S; Kuštrimović N; Vujić V; Dimitrijević M
Peptides; 2011 Aug; 32(8):1626-33. PubMed ID: 21699939
[TBL] [Abstract][Full Text] [Related]
47. Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake.
Abbott CR; Small CJ; Kennedy AR; Neary NM; Sajedi A; Ghatei MA; Bloom SR
Brain Res; 2005 May; 1043(1-2):139-44. PubMed ID: 15862527
[TBL] [Abstract][Full Text] [Related]
48. NPY Y1 antagonists: structure-activity relationships of arginine derivatives and hybrid compounds with arpromidine-like partial structures.
Aiglstorfer I; Uffrecht A; Gessele K; Moser C; Schuster A; Merz S; Malawska B; Bernhardt G; Dove S; Buschauer A
Regul Pept; 1998 Sep; 75-76():9-21. PubMed ID: 9802389
[TBL] [Abstract][Full Text] [Related]
49. Neuropeptide Y modulates effects of bradykinin and prostaglandin E2 on trigeminal nociceptors via activation of the Y1 and Y2 receptors.
Gibbs JL; Diogenes A; Hargreaves KM
Br J Pharmacol; 2007 Jan; 150(1):72-9. PubMed ID: 17143304
[TBL] [Abstract][Full Text] [Related]
50. Neuropeptide Y receptor-expressing dorsal horn neurons: role in nocifensive reflex responses to heat and formalin.
Wiley RG; Lemons LL; Kline RH
Neuroscience; 2009 Jun; 161(1):139-47. PubMed ID: 19138726
[TBL] [Abstract][Full Text] [Related]
51. Pre-diabetes augments neuropeptide Y1- and α1-receptor control of basal hindlimb vascular tone in young ZDF rats.
Novielli NM; Al-Khazraji BK; Medeiros PJ; Goldman D; Jackson DN
PLoS One; 2012; 7(10):e46659. PubMed ID: 23071607
[TBL] [Abstract][Full Text] [Related]
52. Actions of neuropeptide Y on the rat adrenal cortex.
Renshaw D; Thomson LM; Carroll M; Kapas S; Hinson JP
Endocrinology; 2000 Jan; 141(1):169-73. PubMed ID: 10614636
[TBL] [Abstract][Full Text] [Related]
53. Rosiglitazone increases cerebral klotho expression to reverse baroreflex in type 1-like diabetic rats.
Chen LJ; Cheng MF; Ku PM; Lin JW
Biomed Res Int; 2014; 2014():309151. PubMed ID: 24683546
[TBL] [Abstract][Full Text] [Related]
54. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
Kask A; Rägo L; Harro J
Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
[TBL] [Abstract][Full Text] [Related]
55. Involvement of neuropeptide Y Y1 receptors in the regulation of neuroendocrine corticotropin-releasing hormone neuronal activity.
Dimitrov EL; DeJoseph MR; Brownfield MS; Urban JH
Endocrinology; 2007 Aug; 148(8):3666-73. PubMed ID: 17463058
[TBL] [Abstract][Full Text] [Related]
56. Neuropeptide Y increases 4-aminopyridine-sensitive transient outward potassium current in rat ventricular myocytes.
Heredia MP; Fernández-Velasco M; Benito G; Delgado C
Br J Pharmacol; 2002 Apr; 135(7):1701-6. PubMed ID: 11934810
[TBL] [Abstract][Full Text] [Related]
57. Neuropeptide Y-induced enhancement of the evoked release of newly synthesized dopamine in rat striatum: mediation by Y2 receptors.
Adewale AS; Macarthur H; Westfall TC
Neuropharmacology; 2007 May; 52(6):1396-402. PubMed ID: 17382974
[TBL] [Abstract][Full Text] [Related]
58. Effects of a selective neuropeptide Y Y(1) receptor antagonist BIBP 3226 on double peaked vasoconstrictor responses to periarterial nerve stimulation in canine splenic arteries.
Yang XP; Chiba S
Br J Pharmacol; 2000 Aug; 130(7):1699-705. PubMed ID: 10928977
[TBL] [Abstract][Full Text] [Related]
59. Neuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries.
You J; Edvinsson L; Bryan RM
J Cereb Blood Flow Metab; 2001 Jan; 21(1):77-84. PubMed ID: 11149671
[TBL] [Abstract][Full Text] [Related]
60. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y.
Bischoff A; Avramidis P; Erdbrügger W; Münter K; Michel MC
Br J Pharmacol; 1997 Apr; 120(7):1335-43. PubMed ID: 9105710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
